Loading…
Heparin-binding epidermal growth factor–like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis
We have previously demonstrated that enterally administered heparin-binding epidermal growth factor–like growth factor (HB-EGF) decreases the incidence and severity of necrotizing enterocolitis (NEC) in a neonatal rat model. Because apoptosis contributes to gut barrier failure in this model, the aim...
Saved in:
Published in: | Journal of pediatric surgery 2006-04, Vol.41 (4), p.742-747 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We have previously demonstrated that enterally administered heparin-binding epidermal growth factor–like growth factor (HB-EGF) decreases the incidence and severity of necrotizing enterocolitis (NEC) in a neonatal rat model. Because apoptosis contributes to gut barrier failure in this model, the aim of this study was to investigate the effect of HB-EGF on apoptosis during the development of NEC.
NEC was induced in neonatal rats by exposure to hypoxia, hypothermia, hypertonic formula feeding (HHHTF) plus enteral administration of lipopolysaccharide (LPS). Fifty-one neonatal rats were randomly divided into the following groups: (1) breast-fed (BF), (2) HHHTF + LPS, and (3) HHHTF + LPS with HB-EGF (600
μg/kg) added to the formula. NEC was evaluated using a standard histological scoring system. Apoptotic cells in intestinal tissues were detected by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) and by active caspase 3 immunohistochemical staining.
The incidence of NEC in the HHHTF + LPS group was higher than that in the BF group (65% vs 0%,
P < .05). With administration of HB-EGF, the incidence of NEC significantly decreased to 23.8% (
P < .05). The median TUNEL and active caspase 3 scores in the HHHTF + LPS group were higher than those in the BF group (1.9 vs 0.9 and 1.75 vs 0.6, respectively,
P < .05). The median TUNEL and active caspase 3 scores were significantly decreased in the HHHTF + LPS + HB-EGF group compared with the HHHTF + LPS group (1.24 vs 1.9 and 1.0 vs 1.75, respectively,
P < .05).
HB-EGF reduces the incidence of NEC in a neonatal rat model in part by decreasing apoptosis. These results support the use of HB-EGF–based clinical regimens for the treatment of NEC. |
---|---|
ISSN: | 0022-3468 1531-5037 |
DOI: | 10.1016/j.jpedsurg.2005.12.020 |